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Abstract
Invasive infections caused by Trichosporon spp. have increased considerably in recent years, especially in neutropenic and
critically ill patients using catheters and antibiotics. The genus presents limited sensitivity to different antifungal agents, but
triazoles are the first choice for treatment. Here, we investigated the biofilm production and antifungal susceptibility to
triazoles and amphotericin B of 54 Trichosporon spp. isolates obtained from blood samples (19), urine (20) and superficial
mycosis (15). All isolates and 7 reference strains were identified by sequence analysis and phylogenetic inferences of the
IGS1 region of the rDNA. Biofilms were grown on 96-well plates and quantitation was performed using crystal violet
staining, complemented with Scanning Electron Microscopy (SEM). Susceptibility tests for fluconazole, itraconazole,
voriconazole and amphotericin B were processed using the microdilution broth method (CLSI) for planktonic cells and XTT
reduction assay for biofilm-forming cells. Our results showed that T. asahii was the most frequent species identified (66.7%),
followed by T. faecale (11.1%), T. asteroides (9.3%), T. inkin (7.4%), T. dermatis (3.7%) and one T. coremiiforme (1.8%). We
identified 4 genotypes within T. asahii isolates (G1, G3, G4 and G5) and 2 genotypes within T. faecale (G1 and G3). All species
exhibited high adhesion and biofilm formation capabilities, mainly T. inkin, T. asteroides and T. faecale. Microscopy images of
high biofilm-producing isolates showed that T. asahii presented mainly hyphae and arthroconidia, whereas T. asteroides
exhibited mainly short arthroconidia and few filaments. Voriconazole exhibited the best in vitro activity against all species
tested. Biofilm-forming cells of isolates and reference strains were highly resistant to all antifungals tested. We concluded
that levels of biofilm formation by Trichosporon spp. were similar or even greater than those described for the Candida
genus. Biofilm-forming cells were at least 1,000 times more resistant to antifungals than planktonic cells, especially to
voriconazole.
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Introduction
Trichosporon spp. are basidiomycetous yeast-like organisms that
are widely distributed in nature, and can generally be isolated from
soil, water, decomposing matter, and bird and bat droppings [1].
Occasionally, it can be part of the transient human microbiota,
mainly in the skin, nails and mucosa of the respiratory and
gastrointestinal tracts [1,2]. According to data provided by the
ARTEMIS DISK collection, Trichosporon spp. are considered to
be the second or third most commonly isolated yeast species in
clinical laboratories, representing 5.5 to 10.6% of all isolates
[3,4,5].
Trichosporon sp. has been classically associated with white
piedra and hypersensitivity pneumonitis syndrome [1,6,7,8,9].
However, in recent decades, Trichosporon sp. has been recognized
as an important pathogen of systemic infections affecting
immunocompromised patients, mainly those with hematological
malignancies and neutropenia, as well as critically ill patients with
a central venous catheter in place [10,11,12,13].
The genus contains 51 species, 16 of which are able to infect
human hosts [1]. Species identification based on phenotypic
methods usually generates inconsistent results, and none of the
commercially available tests includes new species in the genus in
their databases [14]. Consequently, sequencing of the Intergenic
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Spacer 1 (IGS1) of the rDNA, which presents high variability
within the genus, is a robust method to identify medically
important Trichosporon species [15,16].
There are only a few studies addressing virulence factors in
Trichosporon spp., including biofilm production [17,18,19]. In
addition, there is a lack of information on the antifungal
susceptibility of T. asahii and clinically relevant emergent species
within the genus. Most studies have adapted the Clinical and
Laboratory Standards Institute (CLSI) microdilution method
standardized for testing Candida spp. and Cryptococcus spp. to
evaluate the in vitro antifungal susceptibility of Trichosporon spp.
[12,20,21,22]. Available data suggest that triazoles appear to be
the most effective antifungal class against Trichosporon spp.
[21,23,24,25].
Different species within a genus may have biological peculiar-
ities regarding their virulence mechanisms and drug susceptibility.
In this study, we evaluated the biofilm formation and antifungal
susceptibility profile of 54 clinical isolates of Trichosporon spp.,
whose species identification was confirmed by sequencing the
IGS1 region of the rDNA.
Materials and Methods
Isolates and growth conditions
We tested a total of 54 clinical isolates of Trichosporon spp.
obtained from different patients assisted between 2001 and 2010.
Due to the retrospective character of the study, no informed
consent was required for the IRB Commitee approval. Ethics
Committee number 1497/11. The strains were obtained from
blood (19), urine (20) and superficial sites (skin and hair) (15).
Isolates were sent to the Laborato´rio Especial de Micologia,
Universidade Federal de Sa˜o Paulo, Sa˜o Paulo, Brazil, for
identification and antifungal susceptibility testing. In addition,
the following 7 Trichosporon spp. and 2 Candida spp. reference
strains were added as controls: T. asahii (CBS 2479 e CBS 7631),
T. inkin (CBS 5585), T. dermatis (CBS 2043), T. faecale (CBS
4828), T. mucoides (CBS 7625), T. ovoides (CBS 7556), C.
parapsilosis (ATCC 22019) and C. krusei (ATCC 6258). All
isolates were stored at 280uC in liquid YEPD medium plus 20%
glycerol. Prior to all experiments, the isolates were transferred
twice in CHROMagar Candida for 48 h at 35uC to evaluate their
viability and purity.
Screening of the Trichosporon genus
Phenotypic identification of the genus relied on the macro and
micromorphological (presence of arthroconidia) characteristics of
the colonies as well as a positive urea hydrolysis test [26].
Molecular identification of Trichosporon sp. isolates
Molecular identification was performed by amplification and
sequencing of the IGS1 region from the rDNA according to the
protocol previously described [27]. Sequencing of 2 to 4 reads per
isolate was performed with the BigDye T’erminator Kit (Applied
Biosystems) protocol, and the final sequence was obtained after
alignment and edition in SequencherTM 4.1.4 - Gene Codes.
Final species identification was obtained by comparisons with the
NCBI database (http://ncbi.nlm.nih.gov) using the BLASTn tool.
We considered as criteria for species identification identity and
sequence coverage $ 98% and E-value ,1025 [27,28].
Genotyping analysis
Sequences of the IGS1 region of rDNA from all identified T.
asahii and T. faecale isolates were aligned with sequences of
species deposited in the GenBank (http://www.ncbi.nlm.nih.gov/
genbank/) to check for the presence of genotypes 1 to 12 in T.
asahii and 1 to 3 in T. faecale. Alignments were performed using
the muscle algorithm implemented by SEAVIEW 4.2.12 and
adjusted by eye before haplotype and phylogenetic analyses [29].
Haplotype analysis was implemented in the DNAsp 5.0, excluding
gap positions [30]. Median-joining network was constructed and
visualized using the software Network 4.610 [31]. Bayesian
analysis was performed in MrBayes 3.02 [32].
Biofilm formation
To assess biofilm formation of Trichosporon spp. isolates in a 96-
well plate format, we standardized a protocol adapted from Jin
et al. (2003) and di Bonaventura et al. (2006) [33,34]. We tested
different protocol conditions, such as: inoculum size (105, 106 and
107 cells/ml), adhesion time (60, 90 and 120 min), and biofilm
maturation (48 and 72 h) with static or shaking (75 rpm)
incubation at 37uC. We used the isolates C. tropicalis LEMI 651
and C. metapsilosis LEMI 1799 as control strains because they
were previously characterized as being high and low biofilm
producers, respectively, by Melo et al. (2011) [35]. Clinical isolates
and control strains were cultured in YPD at 35uC for 48 h and
further subcultured under agitation in RPMI 1640 medium
(pH 7.0 - MOPS) overnight at 37uC. Cells were collected by
centrifugation and washed twice with sterile PBS. Cells were
resuspended in RPMI 1640 (pH 7.0 - MOPS) and the inoculum
adjusted to 0.4 O.D. at 530 nm (A530), which corresponds to 10
7
cells/ml. Inocula of 100 ml of the cell suspensions were added to
96-well polystyrene plates with flat bottoms (Techno Plastic
Products, TPP, Switzerland), using 8 wells per isolate. Plates were
incubated at 37uC for 90 min with agitation at 75 rpm. After
incubation, cells were aspirated, and wells were washed twice with
150 ml PBS to remove the non-adherent cells. Finally, 150 ml
RPMI 1640 medium (pH 7.0 - MOPS) was added to each well,
and the plate was incubated at 37uC and 75 rpm for 48 h to allow
biofilm formation. Culture media were changed every 24 hours.
Each experiment was performed in triplicate, and biofilm
quantifications are expressed as means of 24 readings (wells) per
isolate 6 standard deviation.
Biofilm quantification with crystal violet staining
Mature biofilms had the culture medium aspirated, and they
were washed twice with 200 ml sterile PBS to remove non-biofilm-
forming cells. For quantification using crystal violet staining, plates
were dried for 45 min at room temperature. Biofilms were stained
with 110 ml 0.4% aqueous crystal violet (CV) solution for 45 min.
Afterwards, the CV solution was removed, and the wells were
washed 3 to 5 times with 200 mL sterile distilled water. To destain
the biofilms, 200 ml 95% ethanol was added, and the plate was
incubated for 45 min. One hundred ml of the solution were
transferred to another microplate, and the absorbance was read
using a Microplate Reader 680 (BIO RAD, Hercules, USA) at
570 nm.
Scanning electron microscopy (SEM)
Scanning electron microscopy was performed with 3 T. asahii
and 1 T. asteroides isolates selected based on their biofilm
production capabilities. Biofilms were formed on sterile polyvinyl
chloride (PVC) strips (surface area, 0.5 cm2), incubated into 24-
well polystyrene plates with flat bottoms (Techno Plastic Products,
TPP, Switzerland), according to the protocol described previously
[36]. Briefly, all biofilms formed on PVC strips were fixed
overnight at 4uC with a solution composed by 4% formaldehyde
and 2% glutaraldehyde buffered with 0.1 M sodium cacodylate at
pH 7.2. Subsenquently, biofilms were washed repeatedly with 1%
Trichosporon spp. Biofilms and Antifungal Susceptibility
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osmium tetroxide buffered with cacodylate for 1 h, then treated
with 1% tannic acid for 45 min, washed three times with distilled
water for 15 min, and finally, treated with 1% osmium tetroxide
buffered with cacodylate for 1 h. Biofilms were dehydrated with a
graded series of ethanol washes (critical-point dried in CO2) and
coated with gold to be analyzed in the scanning electron
microscope JEOL JSM-5300 (Peabody, MA, USA).
Antifungal susceptibility testing against planktonic and
biofilm-forming cells
We adapted the assay conditions of the Clinical and Laboratory
Standards Institute broth microdilution method (CLSI, M27-A3/
S4) to evaluate the response of planktonic fungal cells to the
following drugs: fluconazole (FLC), itraconazole (ITC), voricona-
zole (VRC) and amphotericin B (AMB). Antifungal compounds
were obtained as pure powders from the manufacturers Pfizer Inc.,
NY, USA and Sigma Chemical Corporation, St. Louis, MO,
USA. Candida parapsilosis ATCC 22019 and C. krusei ATCC
6258 were used as controls.
Susceptibility tests for biofilm-forming cells were processed
following the protocol previously described by Melo et al. (2011)
[35]. Biofilms were grown for 24 h before replacement of the
medium with fresh RPMI 1640 (pH 7.0 - MOPS) supplemented
with the antifungals at the following concentrations: FLC (64-
1024 mg/ml), ITC (1–16 mg/ml), VRC (4–64 mg/ml) and AMB
(2–32 mg/ml). Biofilms were grown for 48 h and quantified
afterwards using the XTT reduction assay. For the XTT (2,3-
Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Car-
boxanilide) reduction assay, a solution containing 200 ml PBS with
12 ml 5:1 1 mg/ml XTT (Sigma Aldrich): Menadione 0.4 mM
(Sigma Aldrich) was used. The plate was incubated for 2 h at 35uC
in the dark to allow XTT metabolization. Thereafter 100 ml of this
solution was transferred to another microplate, and the absor-
bance was read using a Microplate Reader 680 (BIO RAD,
Hercules, USA) at 490 nm.
Minimal Inhibitory Concentrations (MIC) of the drugs on
planktonic cells were determined by visual readings after 48 h of
incubation based on the lower concentration capable of inhibiting
50% of cell growth for azoles and total growth inhibition for AMB.
Biofilm MICs at 48 h were defined as the lowest concentration
capable of inhibiting 50% and 80% of cell growth for azoles and
AMB, respectively [35].
Statistical analysis
We performed comparisons between MIC values generated by
T. asahii and non-T. asahii isolates as well as the biofilm
production among different genotypes of T. asahii and T. faecale,
applying the Mann-Whitney test implemented in the GraphPad
Prism 6.0 software (http://www.graphpad.com/guides/prism/6/
statistics/).
Results
Phenotypic and molecular identification of Trichosporon
isolates
All 54 clinical and 7 reference strains of Trichosporon spp.
included in the analysis were considered pure and viable and
presented morphological and biochemical characteristics compat-
ible with the Trichosporon genus. DNA sequences of the IGS1
region of the rDNA from all isolates ranged from 435 to 630 bp
after contig assembly and editing. For species identification,
alignments performed with the BLASTn tool successfully identi-
fied 58 of 61 Trichosporon spp. isolates with query coverage $
99%, identity$99%, and E-value = 0.0. Three T. faecale isolates
(ST004B, EB087B and EB108A) generated lower identity or
coverage values in the BLASTn searches, 96% and 97%,
respectively. Therefore, their species identification was further
confirmed by phylogenetic analysis (Figure S1). The 54 clinical
isolates were identified as follows: 36 T. asahii, 6 T. faecale, 5 T.
asteroides, 4 T. inkin, 2 T. dermatis and 1 T. coremiiforme (Table 1
and Table S1).
Genotyping of T. asahii and T. faecale isolates
Clinical isolates identified by IGS1 rDNA sequencing as T.
asahii (36) and T. faecale (6) were subjected to phylogenetic
analysis to confirm their identification and characterize their
genotypes (Figure 1 and Figure S1). The network analysis
(Figure 1) showed that 36 clinical isolates identified as T. asahii
grouped into 4 different genotypes: 1, 3, 4 and 5. Trichosporon
asahii G1 comprised 30 clinical isolates, the 2 reference strains
CBS 2479 and CBS 7631, the G1 reference sequence (GenBank
number: AB066386) and the supposedly G11 reference sequence
(GenBank number: EU441160); T. asahii G3 consisted of 3
clinical isolates and the G3 reference sequence (GenBank number:
AB066397); T. asahii G4 grouped 1 clinical isolate and the G4
reference sequence (GenBank number: AB180191); and T. asahii
G5 included 2 clinical isolates and the G5 reference sequence
(GenBank number: AB071387). The other reference sequences
obtained from GenBank that did not grouped with our clinical
isolates were: G2: AB072606, G6: AB180192, G7: AB180194, G8:
AB439002, G9: AB439003, G10: EU441158, and G12: JF412789.
Four of 6 T. faecale clinical isolates and the T. faecale CBS 4828
were classified as genotype 1 (G1 reference sequence number:
AB066413). The isolates EB087B and EB108A had their
molecular identification confirmed as T. faecale genotype 3 (G3
reference sequence number: AB439006). Trichosporon faecale G2
reference sequence (GenBank number: AB439004) did not group
with any of the clinical isolates.
The consensus tree inferred by the Bayesian method (Figure S1)
corroborated the network analysis, confirming the identification of
T. asahii isolates within 4 different genotypes, including the first-
time identification of the genotype 5 among Brazilian isolates and
the identification of ST004B, EB087B and EB108A as T. faecale
isolates.
Biofilm production by Trichosporon spp.
In a pilot study it was tested the protocol conditions for
Trichosporon spp. biofilm formation into 96-well plates. We
observed that 107 cells/ml, 90 min adhesion time and 48 h biofilm
growth at 75 rpm provided the most reproducible results than the
other combinations (data not shown). Comparative analysis of the
quantification by CV method of biofilms grown during 48 and
72 h showed that the last time point returned lower absorbance
values than the first one due to biofilm detachment from the wells,
mostly from isolates that were further classified as high biofilm
producers (data not shown).
The total biofilm mass of 54 clinical isolates and 7 reference
strains of Trichosporon spp. was then assessed by CV staining after
48 h growth. Absorbance values ranged from 0.109 to 3.337. To
correlate the capability for biofilm production with the different
species tested and isolation sites, we arbitrarily established three
categories (33.3 percentiles) of biofilm production based on the
total range of the CV quantifications exhibited by the 61 isolates,
categorizing the producers as follows: low: A570,1, medium:
A570$1.01 to 2.499 or high: A570$2.5. Figure 2 illustrates the
biofilm production by all strains tested according to the isolation
source and species distribution. Trichosporon sp. strains were
scaled from the highest to the lowest biofilm producer as
Trichosporon spp. Biofilms and Antifungal Susceptibility
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T. inkin. T. asteroides < T. faecale. T. asahii. The two T.
dermatis isolates (classified as medium and high biofilm producers)
and the single T. coremiiforme isolate (high biofilm producer) were
not included in this rank scale due to the low number of isolates
tested. When considering the source of isolation, 93.3% of the
Trichosporon spp. strains isolated from skin were categorized as
high or medium biofilm producers. Otherwise, 65% to 73.7% of
the strains isolated from blood and urine, respectively, were
considered high or medium biofilm producers. The reference
strains were characterized as low (T. asahii CBS2479, T. mucoides
CBS7625 and T. faecale CBS4828), medium (T. asahii CBS7631
and T. ovoides CBS7556) or high (T. dermatis CBS2043 and T.
inkin CBS5585) biofilm producers.
There were no significant differences in terms of biofilm
production across different genotypes identified within T. asahii
and T. faecale isolates (Figure 1).
Biofilm Scanning Electron Microscopy Analysis (SEM) of
Trichosporon spp. isolates
To check the efficiency of the CV method to quantify biofilms of
Trichosporon spp., we generated SEM images of 4 Trichosporon
spp. strains categorized as low, medium and high biofilm
Table 1. Species distribution of 54 Trichosporon spp. clinical isolates according to the site of infection or colonization identifiyed
by IGS1 rDNA sequencing.
Species Number of Isolates/Source Total/Percentage
Blood Urine Superficial Mycosis or Skin Colonization
T. asahii 12 20 4 36/66.7%
T. faecale - - 6 6/11.1%
T. asteroides 5 - - 5/9.3%
T. inkin - - 4 4/7.4%
T. dermatis 1 - 1 2/3.7%
T. coremiiforme 1 - - 1/1.8%
Total 19 20 15 54/100%
doi:10.1371/journal.pone.0109553.t001
Figure 1. Median-joining genotypes network of T. asahii, T. faecale and T. coremiiforme based on IGS1 rDNA sequences related to
biofilm quantitation. Dashed square groups the 12 different genotypes (G1 to G12) of T. asahii. Dashed circle groups the 3 different genotypes of
T. faecale. Circumference sizes are proportional to the genotype frequencies. Black dots (mv = median vectors) are hypothetical missing
intermediates.
doi:10.1371/journal.pone.0109553.g001
Trichosporon spp. Biofilms and Antifungal Susceptibility
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producers. The following isolates were analyzed: T. asahii 05-001
(CV-A570 = 0.287), T. asahii 18-001 (CV-A570 = 1.557), T.
asahii 07-001A (CV-A570 = 3.337) and T. asteroides 13-001 (CV-
A570 = 2.755). We observed that all T. asahii isolates produced
micromorphology enriched with hyphae and arthroconidia
regardless of the category of biofilm production (Figure 3 A to
F). Notably, the T. asteroides strain classified as high biofilm
producer exhibited a predominance of blastoconidia and arthro-
conidia, with a few filaments (Figure 3 G and H). We found a high
correlation between SEM images and biofilm quantification by
CV staining in the categorization of isolates as low or high biofilm
producers.
Susceptibility of planktonic and biofilm-forming cells of
Trichosporon spp. isolates against 4 antifungal agents
The MIC readings of susceptibility tests for both planktonic and
biofilm forming cells were performed after 48 h of incubation.
Table 2 summarizes the planktonic MIC50, MIC90, and MIC
ranges (mg/ml) and the geometric means (GM) obtained for the 54
clinical isolates of Trichosporon spp. against 4 antifungal agents.
Of note, T. asahii, T. asteroides and T. faecale isolates exhibited
MIC50 values for AMB $2 mg/ml. Trichosporon asahii isolates
exhibited higher MIC values for all antifungals tested except for
VRZ (Table 2 and Figure 4). Figure 4 depicts the comparison
between MIC values obtained for T. asahii and non-T. asahii
isolates. In general, significant differences were found between the
two groups considering FLC, ITC and AMB, whereas VOR was
the azole that exhibited the best in vitro activity against all
Trichosporon species.
We were not able to compare whether the isolation site had an
impact on the antifungal susceptibility profiles of the Trichosporon
spp. strains because a clear bias of the species distribution was
observed, e.g., T. faecale was identified only among superficial
mycosis isolates, and all isolates identified in urine samples were T.
asahii.
Table 3 summarizes MIC values for all antifungals testes against
biofilm-forming cells. Regardless of the Trichosporon spp. species
or isolation site, all strains were highly resistant to all antifungals
tested.
Discussion
Trichosporon sp. isolates are classically recognized as a cause of
superficial mycoses but have recently emerged as pathogens in
invasive infections, particularly in patients with acute leukemia
and those subjected to invasive clinical procedures [10,37]. It is
still controversial whether there is bias in the distribution of
Trichosporon species among different sites of infection as well as
other putative biological peculiarities of the large number of
recently described species within the genus, such as antifungal
susceptibility and virulence. In this study, we showed that 6
Trichosporon species from 54 clinical isolates obtained from
different types of human infections were able to form robust
biofilms in vitro that were not susceptible to triazoles or
amphotericin B.
Regarding the species distribution within different human sites,
we found that T. asahii was the most frequently isolated species (36
of 54 isolates) in both blood and urine samples, as previously
described by other studies [12,25,38,39]. In addition to T. asahii,
other publications reported that T. mucoides and T. asteroides are
among the species most isolated from invasive fungal infections
due to Trichosporon spp. [27,40]. Curiously, we were not able to
isolate any other species than T. asahii from urine samples. In
contrast, in superficial mycosis or skin colonization, T. inkin, T.
ovoides and T. cutaneum are most commonly found [1]. At this
site, the majority of the isolates were identified by IGS1 rDNA
sequencing as T. faecale, followed by T. inkin and T. asahii.
Phylogenetic analysis of IGS1 sequences confirmed the presence
of 4 different genotypes among T. asahii isolates, with G1 being
the most prevalent in Brazil as previously documented by our
group [27]. Interestingly, we found isolates belonging to T. asahii
G5 and T. faecale G1 and G3 for the first time among Brazilian
isolates. Recently, Xia and collaborators (2012) described three
new genotypes of T. asahii: G10, G11 and G12 [41]. In our
analysis, we failure to differentiate G11 reference sequence from
G1 representatives. Refinement in the analysis of genotypes
including a larger number of isolates is mandatory to resolve
whether or not G11 is a novel genotype or represents an artifact
due to IGS1 sequencing error.
Figure 2. Inter and intra species variation in the biofilm production of 54 Trichosporon spp. clinical isolates and 7 reference strains.
A- 19 isolates from blood identified as T. asahii, T. asteroides, T. coremiiforme and T. dermatis. B- 20 isolates from urine identified as T. asahii. C- 15
isolates from superficial mycosis/skin colonization identified as T. asahii, T. dermatis, T. faecale and T. inkin. D- 7 reference strains from CBS obtained
from different sources.
doi:10.1371/journal.pone.0109553.g002
Figure 3. Scanning electron microscopy of 4 Trichosporon spp. strains grown on catheter surfaces. A and B: Low biofilm producer T.
asahii 05-001 (CV-A570 = 0.287); C and D: Medium biofilm producer T. asahii 18-001 (CV-A570 = 1.557); E and F: High biofilm producer T. asahii 07-
001A (CV-A570 = 3.337); and G and H: High biofilm producer T. asteroides 13-001 (CV-A570 = 2.755).
doi:10.1371/journal.pone.0109553.g003
Trichosporon spp. Biofilms and Antifungal Susceptibility
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Fungal biofilm formation has gained attention among clinicians
specifically due to its capability to increase mortality in patients
with Candida spp. fungemia [42]. In our work, we quantified the
in vitro biofilm formation of 54 clinical isolates belonging to
different Trichosporon species by using the crystal violet staining
method. We verified that isolates representative of the 6
Trichosporon species tested have a high production of biofilms
with quantification values similar to or higher than those described
for Candida spp. In addition, it seems that Trichosporon spp. are
able to produce much more biofilm than other basidiomycetes,
such as Rhodotorula spp. and Cryptococcus spp. [35,36,43,44].
Despite some intraspecific variations in biofilm production, it is
clear that more than half of the isolates representative of different
Trichosporon species were considered to be high biofilm producers
in blood, urine and skin samples. Interestingly, non-T. asahii
isolates obtained from superficial samples produced the same
amount or even more biofilms compared with strains isolated from
blood samples. This finding may reflect the need for high
adherence and biofilm formation to promote colonization and
infection on the skin and in hair samples of human hosts. In the
literature, there are only 3 published studies evaluating slime or
biofilm production, and these exclusively test T. asahii isolates
[19,34,45]. Therefore, to our knowledge, this is the first time that it
has been shown that non-T. asahii isolates are high biofilm
producers.
As already demonstrated with Candida spp. and Rhodototula
spp. strains [35,36], CV is a reliable tool to accurately quantify the
whole biofilm mass produced by fungal cells. Indeed, we
succeeded in demonstrating that the protocol for biofilm formation
on 96-well plates and the quantification by CV staining exhibited
good correlation with SEM images.
After adapting the CLSI protocol for antifungal susceptibility
testing of planktonic cells, we found that AMB has limited in vitro
antifungal activity against T. asahii, T. asteroides and T. faecale.
Not surprisingly, we found that T. asahii isolates exhibited higher
MICs for FLC, ITC and AMB that non-T. asahii isolates,
corroborating the results of other studies [22,24,27,46]. As already
observed, VRC presented the best antifungal activity across all
species tested [24,46]. Considering that triazoles are the antifungal
agents used for first-line treatment of infections caused by
Trichosporon spp., the presence of isolates with high MICs for
this drug class is disturbing. The susceptibility of biofilm-forming
cells demonstrated that all 6 species were intrinsically resistant to
all antifungal agents tested, independent of genotype, isolation site
and biofilm quantification. Considering that voriconazole is
supposed to be the best alternative to treat deep-seated infections
Figure 4. Comparative analysis of MIC values obtained against planktonic cells of T. asahii (36 isolates) versus non-T. asahii (18)
isolates for all antifungals tested. A- Fluconazole; B- Itraconazole; C- Voriconazole and D- Amphotericin B.
doi:10.1371/journal.pone.0109553.g004
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caused by Trichosporon spp., it is disturbing to observe that
biofilm-forming cells presented MICs at least 1,000 times higher
than planktonic cells. Indeed, serum concentrations of the four
antifungal agents tested are substantially lower than the MIC
values that we obtained with all Trichosporon spp. biofilm forming
cells. Recently, Sun et al. (2012) [19] provided data suggesting that
triazoles, AMB and 5-FC are all inefficient against T. asahii
biofilms.
In conclusion, we succeeded in demonstrating that not only T.
asahii but also 5 other species of the genus are able to produce
high amounts of biofilms that impair the efficacy of all antifungal
drugs against biofilm-forming cells. Further studies are necessary
to evaluate whether this finding may correlate with the poor
clinical response observed in a substantial number of patients with
deep-seated infections due to emergent Trichosporon spp.
Supporting Information
Figure S1 Phylogenetic tree and genotypes of 36 T. asahii and 6
T. faecale isolates inferred by the Bayesian method. Reference
sequences obtained from GenBank of T. asahii were G1:
AB066386, G2: AB072606, G3: AB066397, G4: AB180191, G5:
AB071387, G6: AB180192, G7: AB180194, G8: AB439002, G9:
AB439003, G10: EU441158, G11: EU441160, and G12:
JF412789. Reference sequences obtained from GenBank of T.
faecale genotypes were: G1: AB066413, G2: AB439004, and G3:
AB439006.
(EPS)
Table S1 Clinical and microbiological data of 61 Trichosporon
sp. isolates molecularly identified by sequence analysis of the IGS1
region.
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